Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision...

GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another t...

This document is a summary of the European Public Assessment Report (EPAR) for Ozempic.It explains how the Agency's evaluation of the m...